| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18830613 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 101 journal articles in the PubMed database | Email to a friend | | |
| Kim JC, Kim DD, Lee YM, et al.
Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay. [JOURNAL ARTICLE]
Int J Colorectal Dis 2008 Oct 1.
Abstract | Full Citation | Find Related Articles | | Walko CM, Lindley C
Capecitabine: a review. [Journal Article, Review]
Clin Ther 2005 Jan; 27(1):23-44.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hind D, Tappenden P, Tumur I, et al.
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. [Journal Article]
Health Technol Assess 2008 May; 12(15):1-182.
Abstract | Full Citation | | Pandor A, Eggington S, Paisley S, et al.
The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. [Journal Article]
Health Technol Assess 2006 Nov; 10(41):1-204.
Abstract | Full Citation | Find Related Articles | | Hsi LC, Xi X, Lotan R, et al.
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. [Journal Article]
Cancer Res 2004 Dec 1; 64(23):8778-81.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Weichert W, Röske A, Niesporek S, et al.
Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo. [Journal Article]
Clin Cancer Res 2008 Mar 15; 14(6):1669-77.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Saltz LB, Douillard JY, Pirotta N, et al.
Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Oncologist 2001; 6(1):81-91.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Golfinopoulos V, Salanti G, Pavlidis N, et al.
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis. [JOURNAL ARTICLE]
Lancet Oncol 2007 Sep 19.
Abstract | Full Citation | Find Related Articles | | Jordan K, Kellner O, Kegel T, et al.
Phase II trial of capecitabine/irinotecan and capecitabine/oxaliplatin in advanced gastrointestinal cancers. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Clin Colorectal Cancer 2004 May; 4(1):46-50.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
